HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

453.486

-12.837-2.75%

Number of Gainers:8

Number of Losers:38

Number of Flat:5

PE:- -

High:466.335

Open:466.335

Low:452.923

Close:466.322

Volume:443.82M

Turnover:11.07B

Market Cap:2.87T

Float Cap:1.99T

Loading ...

HK-Listed HBM Climbs on Initiating Next Phase of Asthma Drug Study

Hong Kong Stock Market Movers: HBM Holdings-B (02142) Climbs Over 4% in Morning Session After Positive Asthma Trial Results and Stock Connect Inclusion

Jinhai Med Tech Surges Over 21% Intraday as Minimally Invasive Business Jumps More Than Threefold in H1

HAIDILAO (06862) Plunges Over 10% in Morning Trade as Pre-Market Block Deal Sparks Share Sale Speculation

MicroPort Artemis Dream Intracranial Stent Enters China NMPA Innovative Device Review Program

HBM Holdings' Asthma Therapy Shows Promising Phase II Results and Moves to Phase III

HBM Says Partner Windward Bio Starts Phase 3 Asthma Trial of Twice-Yearly TSLP Antibody Hbm9378/win378

Hbm9378/Win378, an Ultra-Long-Acting Antibody Targeting Tslp, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study

THOMSON REUTERS

5万治疗费背后，“毛孩子”的晚年谁来守护？宠物抗癌险应运而生

BAIRONG AI-W (06608) Announces Share Buyback on September 8, Spending HK$77,200

Bairong Files HKEX Next-Day Disclosure Return on Share Buyback at HKD 4.98

HYGEIA HEALTH Spends HK$1.55 Million on Share Buyback on September 8

Hygeia Healthcare Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation

Sunac Services Files HKEX Next-Day Return Disclosing Share Buyback for Cancellation

China Resources Beer Declares Interim Dividend of HKD 0.516 Per Share for H1 2026

China Resources Beer FY26 H1 Profit Drops 10.71% to RMB 5.17 Billion; Turnover Rises 1.2% to RMB 24.24 Billion

China Resources Mixc Lifestyle Services Stock Rises 2.3% in Hong Kong

China Resources Beer (Holdings) Stock Rallies 2.2% in Hong Kong

Hong Kong Market Pulse | CRO Shares Advance as Order Growth Strengthens; AI-Enabled Drug Discovery Poised to Transform Pharma R&D

Hong Kong Stock Market Flash | EVEREST MED Surges Over 5% in Morning Trade as China Approves NDA for PSVT Indication

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/BK1583/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":453.48572,"timestamp":1789027721934,"preClose":466.32224,"halted":0,"volume":443821561,"delay":0,"changeRate":-0.027527,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-12.836517,"latestTime":"09-10 16:00:00","open":466.33533,"high":466.33533,"low":452.92303,"amount":11066675235.5,"amplitude":0.028762,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"pbRate":2.107662,"peRate":44.521524,"turnoverRate":0.004109,"increases":8,"decrements":39,"flats":2,"marketCap":2868178326048,"floatMarketCap":1992251859328},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":466.33533,"amplitude":0.028762,"preClose":466.32224,"low":452.92303,"pbRate":"2.107662","latestPrice":453.48572,"volume":443821561,"delay":0,"open":466.33533,"prevYearClose":503.90085,"prevWeekClose":481.394,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":475.543,"twentyDayClose":491.855,"sixtyDayClose":412.026,"secType":"PLATE","market":"HK","turnoverRate":0.004109,"peRate":44.521524,"marketCap":2868178326048,"floatMarketCap":1992251859328,"timestamp":1789027721934,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":8,"down":38,"flat":5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666033309","title":"HK-Listed HBM Climbs on Initiating Next Phase of Asthma Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666033309","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666033309?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:47","pubTimestamp":1788922062,"startTime":"0","endTime":"0","summary":"BUZZ-HK-listed HBM climbs on initiating next phase of asthma drug study** Shares of HBM Holdings2142.HKclimb 3.7% to HK$15.09** Therapeutics developer says its partner Windward Bio AG reportedpositive","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL1N45102M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02142","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141984241","title":"Hong Kong Stock Market Movers: HBM Holdings-B (02142) Climbs Over 4% in Morning Session After Positive Asthma Trial Results and Stock Connect Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=1141984241","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141984241?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:42","pubTimestamp":1788921769,"startTime":"0","endTime":"0","summary":"Shares of HBM Holdings-B (02142) surged more than 4% during Tuesday's morning trading session, with the stock last changing hands at HK$15.23, up 4.67%, on turnover of approximately HK$59.8...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1583","BK4585","BK1574","BK1161","KCAI","BK4588","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178973209","title":"Jinhai Med Tech Surges Over 21% Intraday as Minimally Invasive Business Jumps More Than Threefold in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=1178973209","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178973209?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:31","pubTimestamp":1788921085,"startTime":"0","endTime":"0","summary":"Jinhai Med Tech (02225) surged more than 21% during Tuesday's trading session, extending its cumulative gain to nearly 60% since being included in the Stock Connect program. As of the time of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1589","BK1100","02225","00853","BK1150","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129110635","title":"HAIDILAO (06862) Plunges Over 10% in Morning Trade as Pre-Market Block Deal Sparks Share Sale Speculation","url":"https://stock-news.laohu8.com/highlight/detail?id=1129110635","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129110635?lang=en_us&edition=fundamental","pubTime":"2026-09-09 09:54","pubTimestamp":1788918851,"startTime":"0","endTime":"0","summary":"Shares of HAIDILAO (06862) plunged over 10% in morning trading, pressuring sentiment in the Hong Kong market.At the time of writing, the stock had fallen 9.14% to HK$10.34, with turnover reaching...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1591","VXUS","06862","BK1233","BK1583","BK4585","LU2488822045.USD","KCAI","BK1589","BK1604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666716953","title":"MicroPort Artemis Dream Intracranial Stent Enters China NMPA Innovative Device Review Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666716953","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666716953?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:16","pubTimestamp":1788884201,"startTime":"0","endTime":"0","summary":"MicroPort Artemis Dream intracranial stent enters China NMPA innovative device review programMicroPort’s Artemis Dream intracranial sirolimus-eluting stent entered China’s NMPA Innovative Medical Devi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL5nfbwg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","00853","BK1100","BK1585","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167922243","title":"HBM Holdings' Asthma Therapy Shows Promising Phase II Results and Moves to Phase III","url":"https://stock-news.laohu8.com/highlight/detail?id=1167922243","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167922243?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:58","pubTimestamp":1788872333,"startTime":"0","endTime":"0","summary":"HBM HOLDINGS-B (02142) has announced that its partner, Windward Bio AG, has reported positive interim results from the Phase II portion of the POLARIS-1 clinical trial evaluating HBM9378/WIN378 for...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1161","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320273","title":"HBM Says Partner Windward Bio Starts Phase 3 Asthma Trial of Twice-Yearly TSLP Antibody Hbm9378/win378","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320273","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320273?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:18","pubTimestamp":1788869907,"startTime":"0","endTime":"0","summary":"HBM says partner Windward Bio starts Phase 3 asthma trial of twice-yearly TSLP antibody HBM9378/WIN378HBM Holdings highlighted positive interim Phase 2 asthma results for HBM9378/WIN378, an ultra-long","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL4WknG1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","BK1583","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320213","title":"Hbm9378/Win378, an Ultra-Long-Acting Antibody Targeting Tslp, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320213","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320213?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869848,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA60HVBV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","02142","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187149909","title":"5万治疗费背后，“毛孩子”的晚年谁来守护？宠物抗癌险应运而生","url":"https://stock-news.laohu8.com/highlight/detail?id=1187149909","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187149909?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868869,"startTime":"0","endTime":"0","summary":"今年8月底，赵先生的爱犬“旺财”被确诊为淋巴瘤。“那一刻，我下定决心要救治旺财，”赵先生回忆道。然而，当宠物医院递来一张超过5万元的治疗费用清单时，他心头还是猛地一紧。“与旺财相伴10余年，实在不忍心看它被恶性肿瘤折磨，”他无奈地表示。作为众安保险宠物险产品总监，李爽敏锐地注意到，在2015年至2019年间的“养宠爆发期”入手的宠物正陆续步入中老年阶段，肿瘤等老年犬猫高发疾病的诊疗需求随之激增。面...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0737861772.HKD","CANC","BK1583","CNCR","06078","LU0329678170.USD","BK1209","LU2488822045.USD","LU0329678337.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163053847","title":"BAIRONG AI-W (06608) Announces Share Buyback on September 8, Spending HK$77,200","url":"https://stock-news.laohu8.com/highlight/detail?id=1163053847","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163053847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:38","pubTimestamp":1788863910,"startTime":"0","endTime":"0","summary":"In a recent regulatory filing, BAIRONG AI-W (06608) disclosed a share repurchase transaction executed on September 8, 2026. The company bought back 15,500 shares at a total cost of HK$77,200.The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1575","BK1583","BK1109","06608","BK1587","BK1131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665661324","title":"Bairong Files HKEX Next-Day Disclosure Return on Share Buyback at HKD 4.98","url":"https://stock-news.laohu8.com/highlight/detail?id=2665661324","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665661324?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:33","pubTimestamp":1788863638,"startTime":"0","endTime":"0","summary":"Bairong files HKEX next-day disclosure return on share buyback at HKD 4.98Bairong filed a next-day disclosure return showing a buyback of 15,500 shares on Sept. 8.Shares were repurchased on HKEX at HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL3jxCst:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1575","BK1587","BK1131","06608","BK1109","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164983756","title":"HYGEIA HEALTH Spends HK$1.55 Million on Share Buyback on September 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1164983756","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164983756?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:54","pubTimestamp":1788861260,"startTime":"0","endTime":"0","summary":"HYGEIA HEALTH (06078) has announced that on September 8, 2026, the company repurchased 151,000 shares for a total consideration of HK$1.5549 million.The buyback was executed at a per-share price ranging between HK$10.28 and HK$10.30, according to the company's official statement.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1583","LU0329678337.USD","BK1209","LU0737861772.HKD","LU0329678170.USD","06078"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329697","title":"Hygeia Healthcare Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329697","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329697?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:47","pubTimestamp":1788860859,"startTime":"0","endTime":"0","summary":"Hygeia Healthcare files HKEX next-day disclosure return on share buyback cancellationHygeia Healthcare filed a next-day disclosure return showing a buyback of 151,000 shares on Sept. 8.All repurchased","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL2qCKjj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06078","LU0329678170.USD","BK1583","LU0329678337.USD","LU2488822045.USD","LU0737861772.HKD","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329846","title":"Sunac Services Files HKEX Next-Day Return Disclosing Share Buyback for Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329846","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329846?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:38","pubTimestamp":1788860307,"startTime":"0","endTime":"0","summary":"Sunac Services files HKEX next-day return disclosing share buyback for cancellationSunac Services reported an on-market buyback of 200,000 shares on Sept. 8.Shares were repurchased at HKD 0.82–0.84 ea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLbGg3JC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1229","BK1542","BK1583","BK1555","BK1258","01918","BK1585","01516","BK1240","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665224326","title":"China Resources Beer Declares Interim Dividend of HKD 0.516 Per Share for H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665224326","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665224326?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:28","pubTimestamp":1788859698,"startTime":"0","endTime":"0","summary":"China Resources Beer declares interim dividend of HKD 0.516 per share for H1 2026China Resources Beer declared an interim dividend of HKD 0.516 per share for the six months ended June 30, 2026.Shareho","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1J9GQZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","IE0008368742.USD","BK1521","IE00BPRC5H50.USD","LU0328353924.USD","BK1510","80291","00291","SG9999006514.SGD","LU1720050803.USD","BK1589","LU1023057109.AUD","LU1769817179.HKD","BK1578","LU0359201612.USD","LU1794554557.SGD","BK1604","BK1180","IE00B543WZ88.USD","BK1570","IE0031814852.USD","LU1769817096.USD","LU0359202008.SGD","IE00B5MMRT66.SGD","LU1328615791.USD","CRHKY","IE00B0169L03.USD","IE00B29SXG58.USD","IE00B031HY20.USD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665963326","title":"China Resources Beer FY26 H1 Profit Drops 10.71% to RMB 5.17 Billion; Turnover Rises 1.2% to RMB 24.24 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2665963326","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665963326?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:15","pubTimestamp":1788858925,"startTime":"0","endTime":"0","summary":"China Resources Beer FY26 H1 profit drops 10.71% to RMB 5.17 billion; turnover rises 1.2% to RMB 24.24 billionChina Resources Beer posted 1H 2026 turnover up 1.2% to RMB 24.24 billion; profit attribut","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL8JB2Hv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE0008369823.USD","IE0008368742.USD","IE00B29SXG58.USD","SG9999006514.SGD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU1023057109.AUD","IE00B031HY20.USD","LU0328353924.USD","LU1794554557.SGD","80291","BK1180","IE0031814852.USD","BK1510","BK1583","BK1521","LU1769817179.HKD","BK1604","LU0359202008.SGD","LU1720050803.USD","LU1769817096.USD","BK1578","CRHKY","IE00B543WZ88.USD","00291","IE00B0169L03.USD","BK1570","LU1328615791.USD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665532533","title":"China Resources Mixc Lifestyle Services Stock Rises 2.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532533","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665532533?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:32","pubTimestamp":1788856320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of China Resources Mixc Lifestyle Services Ltd. rose 2.3% to 40.80 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25317.18.China Resources Mixc Lifestyle Services Ltd. closed 20% short of its 52-week high of HK$51.15, which the company reached May 14.Trading volume totaled 5.6 million shares, compared to the 50-day average of 4.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0082770016.USD","BK1542","LU0164939612.USD","BK1583","01209","LU0456827905.SGD","LU0620787316.HKD","BK1258","LU0456846285.SGD","BK1229","LU0051755006.USD","LU0082770016.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665253973","title":"China Resources Beer (Holdings) Stock Rallies 2.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665253973","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665253973?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:32","pubTimestamp":1788856320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of China Resources Beer  Co. Ltd. rose 2.2% to 19.31 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25317.18.This was the stock's fourth consecutive day of gains.China Resources Beer  Co. Ltd. closed 34% short of its 52-week high of HK$29.40, which the company achieved Sept. 12.Trading volume totaled 13.9 million shares, compared to the 50-day average of 11.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999006514.SGD","IE00B29SXG58.USD","BK1180","IE0031814852.USD","LU0328353924.USD","LU0359202008.SGD","LU1720050803.USD","BK1510","LU1769817179.HKD","00291","LU1023057109.AUD","BK1521","BK1589","BK1570","LU1794554557.SGD","80291","LU1769817096.USD","CRHKY","IE0008369823.USD","IE00B543WZ88.USD","BK1604","LU0359201612.USD","BK1578","LU1328615791.USD","IE00B5MMRT66.SGD","BK1583","IE00B031HY20.USD","IE0008368742.USD","IE00B0169L03.USD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134077786","title":"Hong Kong Market Pulse | CRO Shares Advance as Order Growth Strengthens; AI-Enabled Drug Discovery Poised to Transform Pharma R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=1134077786","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134077786?lang=en_us&edition=fundamental","pubTime":"2026-09-08 13:50","pubTimestamp":1788846618,"startTime":"0","endTime":"0","summary":"CRO-related stocks extended their upward momentum into the afternoon session, with Genscript Bio (01548) surging 10.71% to HK$34.32, Asymchem (06821) climbing 8.5% to HK$142.90, Tigermed (03347)...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK1191","ARTY","03759","BK1574","AGIX","BK1141","BK1583","HK0000306701.USD","LRND","BME","VTHR","AIPO","QTOC","HK0000320223.HKD","06821","01477","HK0000306685.HKD","KCAI","01548","BK4588","VXUS","HK0000320264.USD","BK4585","CHAT","03347","JHMH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167357330","title":"Hong Kong Stock Market Flash | EVEREST MED Surges Over 5% in Morning Trade as China Approves NDA for PSVT Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1167357330","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167357330?lang=en_us&edition=fundamental","pubTime":"2026-09-08 11:56","pubTimestamp":1788839775,"startTime":"0","endTime":"0","summary":"EVEREST MED (01952) saw its share price climb more than 5% during morning trading on Wednesday. As of the time of writing, the stock was up 4.73% to HK$32.78, with trading turnover reaching HK$151...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4588","01952","BK4585","IPOS","VXUS","BK1583","BK1161","KCAI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":5,"totalSize":403,"code":"91000000","status":"200"}]}}